Diabetes drug trial aims to strengthen failing hearts
NCT ID NCT07403955
Summary
This study is testing whether dapagliflozin, a medication originally for diabetes, can help improve heart muscle function in people hospitalized with acute heart failure. Researchers will enroll 188 patients and use special heart ultrasound imaging to measure changes in how well the heart squeezes and relaxes. Participants will take the medication daily for three months while researchers track heart function improvements and hospital readmission rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE ACUTE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.